Hair pulling disorder (trichotillomania): Genes, neurobiology, and a model for understanding impulsivity and compulsivity

Psychiatry Research

Volumn 199, Issue 3, 2012, Pages 151-158

  Flessner, Christopher A ^a   Knopik, Valerie S ^b,c   McGeary, John ^b,c,d  

^a KENT STATE UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Compulsivity; Genes; Hair pulling; Impulsivity; Neurobiology; Pulling styles

Indexed keywords

ACETYLCYSTEINE; CLOMIPRAMINE; DOPAMINE; FLUOXETINE; NALTREXONE; PIMOZIDE; PLACEBO; SEROTONIN TRANSPORTER;

5HT2A GENE; AUTOMATIC PULLING; BEHAVIOR THERAPY; COMPULSION; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; DRD1 GENE; DRD4 GENE; FOCUSED PULLING; GENE; GENETIC ASSOCIATION; HOXB8 GENE; HUMAN; IMPULSIVENESS; LIMBIC SYSTEM; NEUROBIOLOGY; NEUROPATHOLOGY; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SAPAP3 GENE; SEROTONINERGIC SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SLC6A4 GENE; TRICHOTILLOMANIA;

COMPULSIVE BEHAVIOR; HUMANS; IMPULSIVE BEHAVIOR; MODELS, PSYCHOLOGICAL; TRICHOTILLOMANIA;

EID: 84869872719     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.03.039     Document Type: Review

References (102)

1. Abbate-Daga G., Amianto F., Rogna L., Fassino S. Do anorectic men share personality traits with opiate dependent men? A case-control study. Addictive Behavior 2007, 32(1):170-174.
2. Ackerman D.L., Greenland S. Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder. Journal of Clinical Psychopharmacology 2002, 22(3):309-317.
3. Andersen S.L., Greene-Colozzi E.A., Sonntag K.C. A novel, multiple symptom model of obsessive-compulsive-like behaviors in animals. Biological Psychiatry 2010, 68(8):741-747.
4. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. Text Revision (DSM-IV-TR) 2000, APA, Washington, DC. fourth ed.
5. Azrin N.H., Nunn R.G. Habit-reversal: a method of eliminating nervous habits and tics. Behavior Research and Therapy 1973, 11(4):619-628.
6. Bannon S., Gonsalvez C.J., Croft R.J., Boyce P.M. Response inhibition deficits in obsessive-compulsive disorder. Psychiatry Research 2002, 110(2):165-174.
7. Bienvenu O.J., Wang Y., Shugart Y.Y., Welch J.M., Grados M.A., Fyer A.J., Rauch S.L., McCracken J.T., Rasmussen S.A., Murphy D.L., Cullen B., Valle D., Hoehn-Saric R., Greenberg B.D., Pinto A., Knowles J.A., Piacentini J., Pauls D.L., Liang K.Y., Willour V.L., Riddle M., Samuels J.F., Feng G., Nestadt G. Sapap3 and pathological grooming in humans: results from the OCD collaborative genetics study. American Journal of Medical Genetics B-Neuropsychiatric Genetics 2009, 150B(5):710-720.
8. Bloch M.H., Landeros-Weisenberger A., Dombrowski P., Kelmendi B., Wegner R., Nudel J., Pittenger C., Leckman J.F., Coric V. Systematic review: pharmacological and behavioral treatment for trichotillomania. Biological Psychiatry 2007, 62(8):839-846.
9. Blum K., Sheridan P.J., Wood R.C., Braverman E.R., Chen T.J., Cull J.G., Comings D.E. The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. Journal of Research in Social Medicine 1996, 89(7):396-400.
10. Boardman L., van der Merwe L., Lochner C., Kinnear C.J., Seedat S., Stein D.J., Moolman-Smook J.C., Hemmings S.M. Investigating SAPAP3 variants in the etiology of obsessive-compulsive disorder and trichotillomania in the South African white population. Comprehensive Psychiatry 2011, 52(2):181-187.
11. Bohne A., Keuthen N.J., Tuschen-Caffier B., Wilhelm S. Cognitive inhibition in trichotillomania and obsessive-compulsive disorder. Behavior Research and Therapy 2005, 43(7):923-942.
12. Bohne A., Savage C.R., Deckersbach T., Keuthen N.J., Jenike M.A., Tuschen-Caffier B., Wilhelm S. Visuospatial abilities, memory, and executive functioning in trichotillomania and obsessive-compulsive disorder. Journal of Clinical and Experimental Neuropsychology 2005, 27(4):385-399.
13. Bohne A., Savage C.R., Deckersbach T., Keuthen N.J., Wilhelm S. Motor inhibition in trichotillomania and obsessive-compulsive disorder. Journal of Psychiatric Research 2008, 42(2):141-150.
14. Bouwer C., Stein D.J. Trichobezoars in trichotillomania: case report and literature overview. Psychosomatic Medicine 1998, 60(5):658-660.
15. Bowirrat A., Oscar-Berman M. Relationship between dopaminergic neurotransmission, alcoholism, and Reward Deficiency syndrome. American Journal of Medical Genetics B-Neuropsychiatric Genetics 2005, 132B(1):29-37.
16. Britton J.C., Stewart S.E., Killgore W.D., Rosso I.M., Price L.M., Gold A.L., Pine D.S., Wilhelm S., Jenike M.A., Rauch S.L. Amygdala activation in response to facial expressions in pediatric obsessive-compulsive disorder. Depression and Anxiety 2010, 27(7):643-651.
17. Chamberlain S.R., Blackwell A.D., Fineberg N.A., Robbins T.W., Sahakian B.J. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neuroscience Biobehavior Review 2005, 29(3):399-419.
18. Chamberlain S.R., Blackwell A.D., Fineberg N.A., Robbins T.W., Sahakian B.J. Strategy implementation in obsessive-compulsive disorder and trichotillomania. Psychological Medicine 2006, 36(1):91-97.
19. Chamberlain S.R., Fineberg N.A., Blackwell A.D., Clark L., Robbins T.W., Sahakian B.J. A neuropsychological comparison of obsessive-compulsive disorder and trichotillomania. Neuropsychologia 2007, 45(4):654-662.
20. Chamberlain S.R., Fineberg N.A., Blackwell A.D., Robbins T.W., Sahakian B.J. Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. American Journal of Psychiatry 2006, 163(7):1282-1284.
21. Chamberlain S.R., Hampshire A., Menzies L.A., Garyfallidis E., Grant J.E., Odlaug B.L., Craig N., Fineberg N., Sahakian B.J. Reduced brain white matter integrity in trichotillomania: a diffusion tensor imaging study. Archives of General Psychiatry 2010, 67(9):965-971.
22. Chamberlain S.R., Menzies L.A., Fineberg N.A., Del Campo N., Suckling J., Craig K., Muller U., Robbins T.W., Bullmore E.T., Sahakian B.J. Grey matter abnormalities in trichotillomania: morphometric magnetic resonance imaging study. British Journal of Psychiatry 2008, 193(3):216-221.
23. Chamberlain S.R., Odlaug B.L., Boulougouris V., Fineberg N.A., Grant J.E. Trichotillomania: neurobiology and treatment. Neuroscience Biobehavior Review 2009, 33(6):831-842.
24. Christenson G.A., Mackenzie T.B., Mitchell J.E., Callies A.L. A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania. The American Journal of Psychiatry 1991, 148(11):1566-1571.
25. Christenson G.A., Mackenzie T.B., Reeve E.A. Familial trichotillomania. American Journal of Psychiatry 1992, 149(2):283.
26. Cloninger C.R. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatric Developments 1986, 4(3):167-226.
27. Cohen L.J., Stein D.J., Simeon D., Spadaccini E., Rosen J., Aronowitz B., Hollander E. Clinical profile, comorbidity, and treatment history in 123 hair pullers: a survey study. Journal of Clinical Psychiatry 1995, 56(7):319-326.
28. Decloedt E.H., Stein D.J. Current trends in drug treatment of obsessive-compulsive disorder. Journal of Neuropsychiatric Disease and Treatment 2010, 6:233-242.
29. Demetrovics Z., Varga G., Szekely A., Vereczkei A., Csorba J., Balazs H., Hoffman K., Sasvari-Szekely M., Barta C. Association between Novelty Seeking of opiate-dependent patients and the catechol-O-methyltransferase Val(158)Met polymorphism. Comprehensive Psychiatry 2010, 51(5):510-515.
30. Duke D.C., Keeley M.L., Geffken G.R., Storch E.A. Trichotillomania: a current review. Clinical Psychology Review 2010, 30(2):181-193.
31. Eagle D.M., Bari A., Robbins T.W. The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology (Berlin) 2008, 199(3):439-456.
32. Evers E.A., van der Veen F.M., Fekkes D., Jolles J. Serotonin and cognitive flexibility: neuroimaging studies into the effect of acute tryptophan depletion in healthy volunteers. Current Medicinal Chemistry 2007, 14(28):2989-2995.
33. Fassino S., Amianto F., Gramaglia C., Facchini F., Abbate Daga G. Temperament and character in eating disorders: ten years of studies. Eating and Weight Disorders 2004, 9(2):81-90.
34. Ferrao Y.A., Miguel E., Stein D.J. Tourette's syndrome, trichotillomania, and obsessive-compulsive disorder: how closely are they related?. Psychiatry Research 2009, 170(1):32-42.
35. Feusner J.D., Hembacher E., Phillips K.A. The mouse who couldn't stop washing: pathologic grooming in animals and humans. CNS Spectrum 2009, 14(9):503-513.
36. Fineberg N.A., Potenza M.N., Chamberlain S.R., Berlin H.A., Menzies L., Bechara A., Sahakian B.J., Robbins T.W., Bullmore E.T., Hollander E. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology 2010, 35(3):591-604.
37. Flessner C.A., Conelea C.A., Woods D.W., Franklin M.E., Keuthen N.J., Cashin S.E. Styles of pulling in trichotillomania: exploring differences in symptom severity, phenomenology, and functional impact. Behavior Research and Therapy 2008, 46(3):345-357.
38. Flessner C.A., Woods D.W., Franklin M.E., Cashin S.E., Keuthen N.J. The Milwaukee Inventory for Subtypes of Trichotillomania-Adult Version (MIST-A): the development of an instrument for the assessment of "focused" and "automatic" hair pulling. Journal of Psychopathology and Behavioral Assessment 2008, 30:20-30.
39. Flessner C.A., Woods D.W., Franklin M.E., Keuthen N.J., Piacentini J. Styles of pulling in youths with trichotillomania: exploring differences in symptom severity, phenomenology, and comorbid psychiatric symptoms. Behavior Research and Therapy 2008, 46(9):1055-1061.
40. Flessner C.A., Woods D.W., Franklin M.E., Keuthen N.J., Piacentini J. Cross-sectional study of women with trichotillomania: a preliminary examination of pulling styles, severity, phenomenology, and functional impact. Child Psychiatry and Human Development 2009, 40(1):153-167.
41. Flessner C.A., Woods D.W., Franklin M.E., Keuthen N.J., Piacentini J., Cashin S.E., Moore P.S. The Milwaukee Inventory for Styles of Trichotillomania-Child Version (MIST-C): initial development and psychometric properties. Behavior Modification 2007, 31(6):896-918.
42. Franklin M., Flessner C.A., Woods D.W., Keuthen N.J., Piacentini J., Moore P., Stein D.J., Cohen S.B., Wilson M.A. The Child and Adolescent Trichotillomania Impact Project (CA-TIP): exploring phenomenology, functional impact, and comorbid symptoms. Developmental and Behavioral Pediatrics 2007, 29:493-500. Trichotillomania Learning Center-Scientific Advisory Board.
43. Garner J.P., Weisker S.M., Dufour B., Mench J.A. Barbering (fur and whisker trimming) by laboratory mice as a model of human trichotillomania and obsessive-compulsive spectrum disorders. Comprehensive Medicine 2004, 54(2):216-224.
44. Grant J.E., Odlaug B.L., Kim S.W. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. [Randomized Controlled Trial]. Archives of General Psychiatry 2009, 66(7):756-763.
45. Grant J.E., Odlaug B.L., Potenza M.N. Addicted to hair pulling? How an alternate model of trichotillomania may improve treatment outcome. Harvard Review of Psychiatry 2007, 15(2):80-85.
46. Grant J.E., Potenza M.N. Compulsive aspects of impulse-control disorders. Psychiatric Clinics of North America 2006, 29(2):539-551.
47. Graybiel A.M. Habits, rituals, and the evaluative brain. Annual Review of Neuroscience 2008, 31:359-387.
48. Greene-Schloesser D.M., Van der Zee E.A., Sheppard D.K., Castillo M.R., Gregg K.A., Burrow T., Foltz H., Slater M., Bult-Ito A. Predictive validity of a non-induced mouse model of compulsive-like behavior. Behavioural Brain Research 2011, 221(1):55-62.
49. Greer J.M., Capecchi M.R. Hoxb8 is required for normal grooming behavior in mice. Neuron 2002, 33(1):23-34.
50. Hemmings S.M., Kinnear C.J., Lochner C., Seedat S., Corfield V.A., Moolman-Smook J.C., Stein D.J. Genetic correlates in trichotillomania-A case-control association study in the South African Caucasian population. Israel Journal of Psychiatry Related Sciences 2006, 43(2):93-101.
51. Huyser C., Veltman D.J., de Haan E., Boer F. Paediatric obsessive-compulsive disorder, a neurodevelopmental disorder? Evidence from neuroimaging. Neuroscience and Biobehavioral Reviews 2009, 33(6):818-830.
52. Insel T., Cuthbert B., Garvey M., Heinssen R., Pine D.S., Quinn K., Sanislow C., Wang P. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. American Journal of Psychiatry 2010, 167(7):748-751.
53. Keuthen N.J., Makris N., Schlerf J.E., Martis B., Savage C.R., McMullin K., Seidman L.J., Schmahmann J.D., Kennedy D.N., Hodge S.M., Rauch S.L. Evidence for reduced cerebellar volumes in trichotillomania. Biological Psychiatry 2007, 61(3):374-381.
54. Keuthen N.J., Savage C.R., O'Sullivan R.L., Brown H.D., Shera D.M., Cyr P., Jenike M.A., Baer L. Neuropsychological functioning in trichotillomania. Biological Psychiatry 1996, 39(8):747-749.
55. Khan Z.U., Gutierrez A., Martin R., Penafiel A., Rivera A., de la Calle A. Dopamine D5 receptors of rat and human brain. Neuroscience 2000, 100(4):689-699.
56. Laine T.P., Ahonen A., Rasanen P., Pohjalainen T., Tiihonen J., Hietala J. The A1 allele of the D2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics. Alcohol and Alcoholism 2001, 36(3):262-265.
57. Laine T.P., Ahonen A., Rasanen P., Tiihonen J. Dopamine transporter density and novelty seeking among alcoholics. Journal of Addictive Diseases 2001, 20(4):91-96.
58. Lange L.A., Kampov-Polevoy A.B., Garbutt J.C. Sweet liking and high novelty seeking: independent phenotypes associated with alcohol-related problems. Alcohol and Alcoholism 2010, 45(5):431-436.
59. Lee J.A., Kim C.K., Jahng G.H., Hwang L.K., Cho Y.W., Kim Y.J., Bahn G.H. A pilot study of brain activation in children with trichotillomania during a visual-tactile symptom provocation task: a functional magnetic resonance imaging study. Progress in Neuropsychopharmacology and Biological Psychiatry 2010, 34(7):1250-1258.
60. Lenane M.C., Swedo S.E., Rapoport J.L., Leonard H., Sceery W., Guroff J.J. Rates of obsessive compulsive disorder in first degree relatives of patients with trichotillomania: a research note. Journal of Child Psychology and Psychiatry 1992, 33(5):925-933.
61. Lochner C., Hemmings S.M., Kinnear C.J., Nel D., Seedat S., Moolman-Smook J.C., Stein D.J. Cluster analysis of obsessive-compulsive symptomatology: identifying obsessive-compulsive disorder subtypes. Israel Journal of Psychiatry and Related Sciences 2008, 45(3):164-176.
62. Lochner C., Seedat S., du Toit P.L., Nel D.G., Niehaus D.J., Sandler R., Stein D.J. Obsessive-compulsive disorder and trichotillomania: a phenomenological comparison. BMC Psychiatry 2005, 5:2.
63. Lochner C., Stein D.J. Obsessive-compulsive spectrum disorders in obsessive-compulsive disorder and other anxiety disorders. Psychopathology 2010, 43(6):389-396.
64. Loos M., Pattij T., Janssen M.C., Counotte D.S., Schoffelmeer A.N., Smit A.B., Spijker S., van Gaalen M.M. Dopamine receptor D1/D5 gene expression in the medial prefrontal cortex predicts impulsive choice in rats. Cerebral Cortex 2010, 20(5):1064-1070.
65. Marcks B.A., Wetterneck C.T., Woods D.W. Investigating healthcare providers' knowledge of trichotillomania and its treatment. Cognitive and Behavior Therapy 2006, 35(1):19-27.
66. Marsh R., Alexander G.M., Packard M.G., Zhu H., Wingard J.C., Quackenbush G., Peterson B.S. Habit learning in Tourette syndrome: a translational neuroscience approach to a developmental psychopathology. Archives of General Psychiatry 2004, 61(12):1259-1268.
67. Mataix-Cols D., van den Heuvel O.A. Common and distinct neural correlates of obsessive-compulsive and related disorders. Psychiatric Clinics of North America 2006, 29(2):391-410.
68. Mehregan A.M. Trichotillomania. Archives of Dermatology 1970, 102:129-133.
69. Nestadt G., Samuels J., Riddle M., Bienvenu O.J., Liang K.Y., LaBuda M., Walkup J., Grados M., Hoehn-Saric R. A family study of obsessive-compulsive disorder. Archives of General Psychiatry 2000, 57(4):358-363.
70. Nestadt G., Samuels J.F., Riddle M.A., Bienvenu O.J., Liang K.Y., Grados M.A., Cullen B. Obsessive-compulsive disorder: defining the phenotype. Journal of Clinical Psychiatry 2002, 63(Suppl. 6):5-7.
71. Novak C.E., Keuthen N.J., Stewart S.E., Pauls D.L. A twin concordance study of trichotillomania. American Journal of Medical Genetetics B-Neuropsychiatric Genetics 2009, 150B(7):944-949.
72. O'Sullivan R.L., Christenson G.A., Stein D. Pharmacotherapy of trichotillomania. Trichotillomania 1999, 93-124. American Psychiatric Press, Washington, DC. D.J. Stein, G.A. Christenson, E. Hollander (Eds.).
73. O'Sullivan R.L., Rauch S.L., Breiter H.C., Grachev I.D., Baer L., Kennedy D.N., Keuthen N.J., Savage C.R., Manzo P.A., Caviness V.S., Jenike M.A. Reduced basal ganglia volumes in trichotillomania measured via morphometric magnetic resonance imaging. Biological Psychiatry 1997, 42(1):39-45.
74. Phillips K.A., Stein D.J., Rauch S.L., Hollander E., Fallon B.A., Barsky A., Fineberg N., Mataix-Cols D., Ferrão Y.A., Saxena S., Wilhelm S., Kelly M.M., Clark L.A., Pinto A., Bienvenu O.J., Farrow J., Leckman J. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?. Depression and Anxiety 2010, 27(6):528-555.
75. Piero A. Personality correlates of impulsivity in subjects with generalized anxiety disorders. Comprehensive Psychiatry 2010, 51(5):538-545.
76. Potenza M.N., Wasylink S., Epperson C.N., McDougle C.J. Olanzapine augmentation of fluoxetine in the treatment of trichotillomania. The American Journal of Psychiatry 1998, 155(9):1299-1300.
77. Rauch S.L., Wright C.I., Savage C.R., Martis B., McMullin K.G., Wedig M.M., Gold A.L., Keuthen N.J. Brain activation during implicit sequence learning in individuals with trichotillomania. Psychiatry Research: Neuroimaging 2007, 154(3):233-240.
78. Ray L.A., Bryan A., Mackillop J., McGeary J., Hesterberg K., Hutchison K.E. The dopamine D Receptor (DRD4) gene exon III polymorphism, problematic alcohol use and novelty seeking: direct and mediated genetic effects. Addiction Biology 2009, 14(2):238-244.
79. Retz W., Rosler M., Supprian T., Retz-Junginger P., Thome J. Dopamine D3 receptor gene polymorphism and violent behavior: relation to impulsiveness and ADHD-related psychopathology. Journal of Neural Transmission 2003, 110(5):561-572.
80. Saxena S., Rauch S.L. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatric Clinics of North America 2000, 23(3):563-586.
81. Scherk H., Backens M., Schneider-Axmann T., Kraft S., Kemmer C., Usher J., Reith W., Falkai P., Meyer J., Gruber O. Dopamine transporter genotype influences N-acetyl-aspartate in the left putamen. World Journal of Biological Psychiatry 2009, 10(4 Pt 2):524-530.
82. Schlosser S., Black D.W., Blum N., Goldstein R.B. The demography, phenomenology, and family history of 22 persons with compulsive hair pulling. Annals of Clinical Psychiatry 1994, 6(3):147-152.
83. Simon D., Kaufmann C., Musch K., Kischkel E., Kathmann N. Fronto-striato-limbic hyperactivation in obsessive-compulsive disorder during individually tailored symptom provocation. Psychophysiology 2010, 47(4):728-738.
84. Srivastava R.K., Sharma S., Tiwari N., Saluja B. Olanzapine augmentation of fluoxetine in trichotillomania: two cases. The Australian and New Zealand Journal of Psychiatry 2005, 39(1-2):112-113.
85. Stanley M.A., Hannay H.J., Breckenridge J.K. The neuropsychology of trichotillomania. Journal of Anxiety Disorders 1997, 11(5):473-488.
86. Stein D.J., Coetzer R., Lee M., Davids B., Bouwer C. Magnetic resonance brain imaging in women with obsessive-compulsive disorder and trichotillomania. Psychiatry Research 1997, 74(3):177-182.
87. Stein D.J., Spadaccini E., Hollander E. Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder. International Clinical Psychopharmacology 1995, 10:11-18.
88. Stein D.J., Hollander E. Low-dose augmentation of serotonin reuptake blockers in the treatment of trichotllomania. Journal of Clinical Psychiatry 1992, 53(4):123-126.
89. Stein D.J., van Heerden B., Hugo C., van Kradenburg J., Warwick J., Zungu-Dirwayi N., Seedat S. Functional brain imaging and pharmacotherapy in trichotillomania. Single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram. Progress in Neuropsychopharmacology and Biological Psychiatry 2002, 26(5):885-890.
90. Streichenwein S.M., Thornby J.I. A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania. The American Journal of Psychiatry 1995, 152(8):1192-1196.
91. Suzuki M., Hurd Y.L., Sokoloff P., Schwartz J.C., Sedvall G. D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Research 1998, 779(1-2):58-74.
92. Swedo S.E., Lenane M.C., Leonard H.L. Long-term treatment of trichotillomania (hair pulling). The New England Journal of Medicine 1993, 329(2):141-142.
93. Swedo S.E., Rapoport J.L. Annotation: trichotillomania. Journal of Child Psychology and Psychiatry 1991, 32(3):401-409.
94. Swedo S.E., Rapoport J.L., Leonard H.L., Schapiro M.B., Rapoport S.I., Grady C.L. Regional cerebral glucose metabolism of women with trichotillomania. Archives of General Psychiatry 1991, 48(9):828-833.
95. Tolin D.F., Franklin M.E., Diefenbach G.J., Anderson E., Meunier S.A. Pediatric trichotillomania: descriptive psychopathology and an open trial of cognitive behavioral therapy. Cognitive and Behavior Therapy 2007, 36(3):129-144.
96. Van Ameringen M., Mancini C., Patterson B., Bennett M., Oakman J. A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania. Journal of Clinical Psychiatry 2010, 71(10):1336-1343.
97. Vollstadt-Klein S., Wichert S., Rabinstein J., Buhler M., Klein O., Ende G., Herrmann D., Mann K. Initial, habitual and compulsive alcohol use is characterized by a shift of cue processing from ventral to dorsal striatum. Addiction 2010, 105(10):1741-1749.
98. Welch J.M., Lu J., Rodriguiz R.M., Trotta N.C., Peca J., Ding J.D., Feliciano C., Chen M., Adams J.P., Luo J., Dudek S.M., Weinberg R.J., Calakos N., Wetsel W.C., Feng G. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 2007, 448(7156):894-900.
99. Woods D.W., Flessner C.A., Franklin M.E., Keuthen N.J., Goodwin R.D., Stein D.J., Walther M.R. The Trichotillomania Impact Project (TIP): exploring phenomenology, functional impairment, and treatment utilization. Journal of Clinical Psychiatry 2006, 67(12):1877-1888.
100. Woods D.W., Piacentini J., Himle M.B., Chang S. Premonitory Urge for Tics Scale (PUTS): initial psychometric results and examination of the premonitory urge phenomenon in youths with tic disorders. Journal of Developmental and Behavioral Pediatrics 2005, 26(6):397-403.
101. Woods D.W., Wetterneck C.T., Flessner C.A. A controlled evaluation of acceptance and commitment therapy plus habit reversal for trichotillomania. Behavior Research and Therapy 2006, 44(5):639-656.
102. Zuchner S., Wendland J.R., Ashley-Koch A.E., Collins A.L., Tran-Viet K.N., Quinn K., Timpano K.C., Cuccaro M.L., Pericak-Vance M.A., Steffens D.C., Krishnan K.R., Feng G., Murphy D.L. Multiple rare SAPAP3 missense variants in trichotillomania and OCD. Molecular Psychiatry 2009, 14(1):6-9.